It's really interesting to see clinicians gave better improvement scores than caregivers too. i assume this is very reassuring as isn't this usually the other way around i.e. clinicians are more moderate in scoring?
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-36
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.88 |
Change
1.340(10.7%) |
Mkt cap ! $1.728B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $6.511M | 479.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 326 | $13.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.89 | 125 | 3 |
View Market Depth
| Last trade - 11.21am 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |